Point72 Hong Kong Ltd - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 183 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$42,000
-61.1%
24,515
+13.6%
0.00%
-75.0%
Q4 2021$108,000
+83.1%
21,587
+160.2%
0.00%
+100.0%
Q3 2021$59,000
+96.7%
8,297
+157.9%
0.00%
+100.0%
Q1 2021$30,000
+76.5%
3,217
+69.0%
0.00%0.0%
Q4 2020$17,000
+750.0%
1,903
+1012.9%
0.00%
Q3 2020$2,000
-94.6%
171
-98.5%
0.00%
-100.0%
Q4 2019$37,000
+208.3%
11,220
+167.6%
0.01%
+200.0%
Q2 2019$12,000
+1100.0%
4,193
+1557.3%
0.00%
+200.0%
Q1 2018$1,0002530.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders